ATTO
Attovia Therapeutics, Inc.
Set alert
15.19 USD -0.08 -0.52%
13.77 Day range 15.99
13.73 52-week range 25.55
- YTD
- -30.64%
- 1 year
- -30.64%
- Open
- 15.30
- Prev close
- 15.27
- Mkt cap
- 693.44M
- Vol
- 146.67K
- Avg vol
- 437.49K
- EPS
- -2.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.77
- High
- 15.99
- Forward P/E
- -9.30
- Beta
- 0.00
- Short ratio
- 0.54
- Inst. own
- 40.86%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 21.62
- 200-d avg
- 21.62
- 1y target
- 42.20
Financial health
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -15.4×
FY 2024 5y median -18.1× FY 2025
P/S 698×
FY 2024 5y median 349× FY 2025
P/B 6.2×
FY 2024 5y median 10.7× FY 2025
P/FCF -15.3×
FY 2024 5y median -20.5× FY 2025
EV/EBITDA -13.7×
FY 2024 5y median -17.9× FY 2025
EV/Sales 672×
FY 2024 5y median 336× FY 2025
FCF Yield -6.5%
FY 2024 5y median -5.2% FY 2025
Profitability
Gross Margin 40.4%
FY 2024 5y median 20.2% FY 2025
Operating Margin -4974.7%
FY 2024 5y median -2487.4% FY 2025
Net Margin -4490.9%
FY 2024 5y median -2245.4% FY 2025
ROE -40.2%
FY 2024 5y median -52.1% FY 2025
ROIC -42.8%
FY 2024 5y median -51.5% FY 2025
ROA -36.5%
FY 2024 5y median -44.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -61.6%
FY 2024 FY 2025
EPS (diluted) -35.2%
FY 2024 FY 2025
Free Cash Flow -67.1%
FY 2024 FY 2025
Financial Health
Current Ratio 14.2×
FY 2024 5y median 11.8× FY 2025
Quick Ratio 14.2×
FY 2024 5y median 11.8× FY 2025
Debt / Equity 0.0×
FY 2024 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2024 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31